Showing results (391-400 of 2,556) with videos related to
Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|September 24, 2015
The clinical application of linagliptin in AsiansChu-Qing Cao, Yu-Fei Xiang, Zhi-Guang ZhouTherapeutics and Clinical Risk Management|October 8, 2015
Tumor necrosis factor-alpha G-238A polymorphism and coronary artery disease risk: a meta-analysis of 4,222 patients and 4,832 controlsXian-Ping Hua, Xiao-Dong Zhang, Joey Sw Kwong, et al.Therapeutics and Clinical Risk Management|October 28, 2015
Cigarette smoke is a risk factor for severity and treatment outcome in patients with culture-positive tuberculosisHsiao-Chi Chuang, Chien-Ling Su, Hui-Chiao Liu, et al.Therapeutics and Clinical Risk Management|October 29, 2015
Mandibular bone mineral density in patients with Behçet's diseaseFatih Asutay, Yusuf Atalay, Ahmet Hüseyin Acar, et al.Therapeutics and Clinical Risk Management|October 29, 2015
Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 casesTomas Vymazal, Martina Krecmerova, Vladimír Bicek, et al.Therapeutics and Clinical Risk Management|November 4, 2015
Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centersGiorgio Lorenzo Colombo, Calogero Cammà, Adolfo Francesco Attili, et al.Therapeutics and Clinical Risk Management|February 9, 2016
Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational studyGiuseppe Gregori, Ornella Righi, Paolo Risso, et al.Therapeutics and Clinical Risk Management|March 2, 2016
IgG4-related disease: current challenges and future prospectsDavid Lang, Jochen Zwerina, Herwig PieringerTherapeutics and Clinical Risk Management|March 2, 2016
Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusionsAnna W Chalmers, Jamile M ShammoTherapeutics and Clinical Risk Management|March 4, 2016
Effect of a nonsurgical treatment program on the gait pattern of idiopathic toe walking: a case reportAndrzej Szopa, Małgorzata Domagalska-Szopa, Weronika Gallert-Kopyto, et al.Pageof 256